Bladder Cancer in Iran: An Epidemiological Review

References

• Afsharmoghadam N, Haghighatian Z, Mazdak H, Mirkheshti N, Koushki RM, Alavi SA. Concentration-dependent effects of curcumin on 5-fluorouracil efficacy in bladder cancer cells. Asian Pac J Cancer Prev. 2017;18(12):3225–3230. doi:10.22034/APJCP.2017.18.12.322529281876
   PubMedGoogle Scholar
• Aghaalikhani N, Rashtchizadeh N, Shadpour P, Allameh A, Mahmoodi M. Cancer stem cells as a therapeutic target in bladder cancer. J Cell Physiol. 2019;234(4):3197–3206. doi:10.1002/jcp.2691630471107
   PubMed Web of Science ®Google Scholar
• Cumberbatch MGK, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795. doi:10.1016/j.eururo.2018.09.00130268659
   PubMed Web of Science ®Google Scholar
• Diet N Physical activity and bladder cancer; 2015 Available from: https://www.cancerpreventionscotland.org.uk/research/diet-nutrition-physical-activity-and-bladder-cancer. Accessed 23, 2020.
   Google Scholar
• Hassanipour S, Delam H, Fathalipour M, et al. The incidence of bladder cancer in Iran: a systematic review and meta-analysis. WCRJ. 2019;6:e1222.
   Google Scholar
• Ahmadi M, Ranjbaran H, Amiri MM, et al. Epidemiologic and socioeconomic status of bladder cancer in Mazandaran Province, Northern Iran. Asian Pac J Cancer Prev. 2012;13(10):5053–5056. doi:10.7314/APJCP.2012.13.10.505323244109
   PubMedGoogle Scholar
• Shakhssalim N, Hosseini SY, Basiri A, Eshrati B, Mazaheri M, Soleimanirahbar A. Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev. 2010;11(3):601–606.21039023
   PubMedGoogle Scholar
• Wong MC, Fung FD, Leung C, Cheung WW, Goggins WB, Ng C. The global epidemiology of bladder cancer: a join point regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129.29348548
   PubMed Web of Science ®Google Scholar
• Pishgar F, Amini E, Gohari K, et al. National and subnational mortality of urological cancers in Iran, 1990–2015. Asia Pac J Clin Oncol. 2019;15(2):e43–e48. doi:10.1111/ajco.1307430270510
   PubMed Web of Science ®Google Scholar
• Asgari M, Safarinejad M, Shakhssalim N, Soleimani M, Shahabi A, Amini E. Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: a comparative study. Urol Ann. 2013;5(3):190. doi:10.4103/0974-7796.11574724049384
   PubMedGoogle Scholar
• Tabibi A, Simforoosh N, Parvin M, et al. Predictive factors for prostatic involvement by transitional cell carcinoma of the bladder. Urol J. 2011;8(1):43–47.21404202
   PubMed Web of Science ®Google Scholar
• Ferlay J. Estimated cancer incidence, mortality and prevalence worldwide in 2012. GLOBOCAN. 2012 Available from: https://publications.iarc.fr › Databases › Iarc-Cancerbases › GLOBOCAN-2. Accessed 23, 2020.
   Google Scholar
• Ahmad E, Ghasem Khani O, Dastoori P. Recurrence rate and prognostic factors of superficial bladder cancer in shiraz shahid faghihi hospital during the years 1998–2001. J Adv Med Biomed Res. 2003;11(42):1–7.
   Google Scholar
• Mohammadbeigi A, Zadeh AR. Application of life table in survival analysis of patients with bladder cancer. ZJRMS. 2011;13(3):25–29.
   Google Scholar
• Mazdak H, Tolou-Ghamari Z. Preliminary study of prevalence for bladder cancer in Isfahan Province, Iran. Arab J Urol. 2018;16(2):206–210. doi:10.1016/j.aju.2017.11.01729892483
   PubMed Web of Science ®Google Scholar
• Cumberbatch MG, Noon AP. Epidemiology, aetiology and screening of bladder cancer. Transl Androl Urol. 2019;8(1):5. doi:10.21037/tau.2018.09.1130976562
   PubMed Web of Science ®Google Scholar
• Aliasgari M, Kaviani A, Gachkar L, Hosseini-Nassab S. Is bladder cancer more common among opium addicts? Urol J. 2009;1(4):253–2535.
   Google Scholar
• Akbari M, Naghibzadeh TA, Khanjani N, et al. Opium as a risk factor for bladder cancer: a population-based case-control study in Iran. Arch Iran Med. 2015;18(9):567–571. doi:0151809/AIM.00426317596
   PubMed Web of Science ®Google Scholar
• Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci. 2005;5(2):380–382. doi:10.3923/jas.2005.380.382
   Google Scholar
• Nakhaee N, Divsalar K, Meimandi MS, Dabiri S. Estimating the prevalence of opiates use by unlinked anonymous urine drug testing: a pilot study in Iran. Subst Use Misuse. 2008;43(3–4):513–520. doi:10.1080/1082608070177234818365947
   PubMed Web of Science ®Google Scholar
• Yavari P, Sadrolhefazi B, Mohagheghi M, Mehrazin R. A descriptive retrospective study of bladder cancer at a hospital in Iran (1973–2003). Asian Pac J Cancer Prev. 2009;10(4):681–684.19827894
   PubMedGoogle Scholar
• Zaitsu M, Nakamura F, Toyokawa S, et al. Risk of alcohol consumption in bladder cancer: case-control study from a nationwide inpatient database in Japan. Tohoku J Exp Med. 2016;239(1):9–15. doi:10.1620/tjem.239.927098227
   PubMed Web of Science ®Google Scholar
• Botteri E, Ferrari P, Roswall N, et al. Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2017;141(10):1963–1970. doi:10.1002/ijc.v141.1028722206
   PubMed Web of Science ®Google Scholar
• Di Maso M, Bosetti C, Taborelli M, et al. Dietary water intake and bladder cancer risk: an Italian case–control study. Cancer Epidemiol. 2016;45:151–156. doi:10.1016/j.canep.2016.09.01527821348
   PubMed Web of Science ®Google Scholar
• Temraz S, Haibe Y, Charafeddine M, Saifi O, Mukherji D, Shamseddine A. The unveiling of a new risk factor associated with bladder cancer in Lebanon. BMC Urol. 2019;19(1):16. doi:10.1186/s12894-019-0445-930836962
   PubMed Web of Science ®Google Scholar
• Burger M, Catto J, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–241. doi:10.1016/j.eururo.2012.07.03322877502
   PubMed Web of Science ®Google Scholar
• Bravi F, Spei M-E, Polesel J, et al. Mediterranean diet and bladder cancer risk in Italy. Nutrients. 2018;10(8):1061. doi:10.3390/nu10081061
   PubMed Web of Science ®Google Scholar
• Pelucchi C, Galeone C, Tramacere I, et al. Alcohol drinking and bladder cancer risk: a meta-analysis. Ann Oncol. 2011;23(6):1586–1593. doi:10.1093/annonc/mdr46022039083
   PubMed Web of Science ®Google Scholar
• Murta-Nascimento C, Silverman DT, Kogevinas M, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev. 2007;16(8):1595–1600. doi:10.1158/1055-9965.EPI-06-074317684133
   PubMed Web of Science ®Google Scholar
• Qin Q, Xu X, Wang X, Zheng X-Y. Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev. 2013;14(5):3117–3121. doi:10.7314/APJCP.2013.14.5.311723803089
   PubMedGoogle Scholar
• Farma KKF, Jalili Z, Zareban I, Pour MS. Effect of education on preventive behaviors of breast cancer in female teachers of guidance schools of Zahedan city based on health belief model. J Educ Health Promot. 2014;3.24741643
   PubMedGoogle Scholar
• Piyathilake C. Dietary factors associated with bladder cancer. Invest Clin Urol. 2016;57(Suppl 1):S14–S25. doi:10.4111/icu.2016.57.S1.S14
   PubMed Web of Science ®Google Scholar
• Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011;204(2):217–223. doi:10.1093/infdis/jir24821673031
   PubMed Web of Science ®Google Scholar
• Khoubi J, Pourabdian S, Mohebbi I, Tajvidi M, Zaroorian O, Giahi O. Association between the high risk occupations and bladder cancer in Iran: a case-control study. Int J Occup Med Environ Health. 2013;26(2):205–213. doi:10.2478/s13382-013-0103-523690263
   PubMed Web of Science ®Google Scholar
• Noon AP, Martinsen JI, Catto JW, Pukkala E. Occupation and bladder cancer phenotype: identification of workplace patterns that increase the risk of advanced disease beyond overall incidence. Eur Urol Focus. 2018;4(5):725–730. doi:10.1016/j.euf.2016.06.01428753772
   PubMedGoogle Scholar
• Aminian O, Saburi A, Mohseni H, Akbari H, Chavoshi F, Akbari H. Occupational risk of bladder cancer among Iranian male workers. Urol Ann. 2014;6(2):135. doi:10.4103/0974-7796.13064324833825
   PubMedGoogle Scholar
• Hosseini SY, Safarinejad MR, Amini E, Hooshyar H, editors. Opium consumption and risk of bladder cancer: a case-control analysis. Urol Oncol. 2010;28(6):610–616. doi:10.1016/j.urolonc.2008.10.01619110453
   PubMed Web of Science ®Google Scholar
• Farzaneh F, Mehrparvar AH, Lotfi MH. Occupations and the risk of bladder cancer in Yazd Province: a Case-Control study. Int J Occup Environ Med. 2017;8:191–198. doi:10.15171/ijoem.2017.108528970593
   PubMed Web of Science ®Google Scholar
• Ghadimi T, Gheitasi B, Nili S, Karimi M, Ghaderi E. Occupation, smoking, opium, and bladder cancer: a case–control study. South Asian J Cancer. 2015;4(3):111. doi:10.4103/2278-330X.17317426942139
   PubMedGoogle Scholar
• Lotfi M, Bagheri M, Mosleh-Shirazi M, Faghihi R, Baradaran-Ghahfarokhi M. Evaluation of the changes in the shape and location of the prostate and pelvic organs due to bladder filling and rectal distension. Iran Red Crescent Med J. 2011;54:26–67.
   Google Scholar
• Mohseni MG, Zand S, Aghamir SMK. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Urol J. 2009;1(4):250–252.
   Google Scholar
• Motamed S, Aminsharifi A, Vardanjani H, Salehi A. Bladder cancer in southwestern Iran: histopathologic and clinical features. Pak J Med Health Sci. 2018;12(2):884–888.
   Web of Science ®Google Scholar
• Mirsafa F, Abdolahi M, Houshiar Rad A. The relationship between food intake and bladder cancer: a Case Control study. YUMSJ. 2015;19(10):828–840.
   Google Scholar
• Jafari-Koshki T, Arsang-Jang S, Mahaki B. Bladder cancer in Iran: geographical distribution and risk factors. Iran J Cancer Prev. 2017;10:2.
   Google Scholar
• Mahaki B, Mehrabi Y, Kavousi A, et al. Multivariate disease mapping of seven prevalent cancers in Iran using a shared component model. Asian Pac J Cancer Prev. 2011;12(9):2353–2358.22296383
   PubMedGoogle Scholar
• Eslami G, Golshani M, Rakhshan M, Fallah F, Goudarzi H, Taghavi A. Surveying human papiloma virus (HPV) in patients with bladder cancer by PCR. Res Med. 2007;31(4):339–343.
   Google Scholar
• Vahedian-Ardakani H-A, Moghimi M, Shayestehpour M, Doosti M, Alimohammadi F. Survival rate of patients with bladder cancer in Yazd, central province of Iran. Int J Cancer Manag. 2018;11(5). doi:10.5812/ijcm
   Web of Science ®Google Scholar
• Somi MH, Farhang S, Mirinezhad SK, Naghashi S, Seif-Farshad M, Golzari M. Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2008;9(2):327–330.18712985
   PubMedGoogle Scholar
• Akbari ME, Hosseini SJ, Rezaee A, Hosseini MM, Rezaee I, Sheikhvatan M. Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev. 2008;9(4):549–552.19256736
   PubMedGoogle Scholar
• Rohani-Rasaf M, Moradi-Lakeh M, Ramezani R, Asadi-Lari M. Measuring socioeconomic disparities in cancer incidence in Tehran, 2008. Asian Pac J Cancer Prev. 2012;13(6):2955–2960. doi:10.7314/APJCP.2012.13.6.295522938489
   PubMedGoogle Scholar
• Ahmadi A, Salehi F. Evaluation of observed and the expected incidence of common cancers: an experience from Southwestern of Iran, 2010–2014. J Res Med Sci. 2018;23. doi:10.4103/jrms.JRMS_788_17
   Web of Science ®Google Scholar
• Shahesmaeili A, Afshar RM, Sadeghi A, Bazrafshan A. Cancer incidence in Kerman Province, Southeast of Iran: report of an ongoing population-based cancer registry, 2014. Asian Pac J Cancer Prev. 2018;19(6):1533.29936728
   PubMedGoogle Scholar
• Akbarzadeh PA, Mohammadi KH, ALIZADEH NR, Hajian K. The incidence of bladder cancer in Mazandaran province for three years. JBUMS. 2012;14(3):80–84.
   Google Scholar
• Amori N, Aghajani M, Asgarian F, Jazayeri M. Epidemiology and trend of common cancers in Iran (2004–2008). Eur J Cancer Care. 2017;26(5):e12449. doi:10.1111/ecc.2017.26.issue-5
   Web of Science ®Google Scholar
• Babaei M, Jaafarzadeh H, Sadjadi A, et al. Cancer incidence and mortality in Ardabil: report of an ongoing population-based cancer registry in Iran, 2004–2006. Iran J Public Health. 2009;35–45.
   Web of Science ®Google Scholar
• Basiri A, Shakhssalim N, Jalaly NY, Miri HH, Partovipour E, Panahi MH. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran. Asian Pac J Cancer Prev. 2014;15(3):1459–1463. doi:10.7314/APJCP.2014.15.3.145924606483
   PubMedGoogle Scholar
• Haghdoost AA, Baneshi MR, Haji-Maghsoodi S, Molavi-Vardanjani H, Mohebbi E. Application of a network scale-up method to estimate the size of population of breast, ovarian/ cervical, prostate and bladder cancers. Asian Pac J Cancer Prev. 2015;16(8):3273–3277. doi:10.7314/APJCP.2015.16.8.327325921131
   PubMedGoogle Scholar
• Rafiemanesh H, Zahedi A, Mehtarpour M, et al. Cancer epidemiology and trends in North Khorasan Province of Iran. Clin Epidemiol Glob Health. 2018;6(2):51–55. doi:10.1016/j.cegh.2018.02.001
   Web of Science ®Google Scholar
• Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, Salehiniya H, Enayatrad M, Khazaei S. Cancer epidemiology and trends in Sistan and Baluchestan province, Iran. Med J Islam Repub Iran. 2015;29:254.26793645
   PubMedGoogle Scholar
• Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, trends and epidemiology of cancers in north west of Iran. Asian Pac J Cancer Prev. 2015;16(16):7189–7193. doi:10.7314/APJCP.2015.16.16.718926514510
   PubMedGoogle Scholar
• Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil: results of a population‐based cancer registry from Iran. Int J Cancer. 2003;107(1):113–118. doi:10.1002/(ISSN)1097-021512925965
   PubMed Web of Science ®Google Scholar
• Sadjadi A, Zahedi M, Nouraie M, et al. The first population-based cancer survey in Kerman Province of Iran. Iran J Public Health. 2007;36(4):26–34.
   Web of Science ®Google Scholar
• Somi MH, Dolatkhah R, Sepahi S, et al. Cancer incidence in the East Azerbaijan province of Iran in 2015–2016: results of a population-based cancer registry. BMC Public Health. 2018;18(1):1266. doi:10.1186/s12889-018-6119-930453968
   PubMed Web of Science ®Google Scholar
• Salehiniya H, Dashdebi SG, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M. Time trend analysis of cancer incidence in Caspian Sea, 2004–2009: a population-based cancer registries study (Northern Iran). Caspian J Intern Med. 2016;7(1):25.26958329
   PubMedGoogle Scholar
• Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S. Cancer incidence in southwest of iran: first report from khuzestan population-based cancer registry, 2002–2009. Asian Pac J Cancer Prev. 2013;14(12):7517–7522. doi:10.7314/APJCP.2013.14.12.751724460327
   PubMedGoogle Scholar
• Fararouei M, Parisai Z, Farahmand M, Haghighi RE, Toori MA. Cancer incidence appears to be rising in a small province in Islamic Republic of Iran: a population-based cohort study. East Mediterr Health J. 2015;21(5):319. doi:10.26719/2015.21.5.31926343120
   PubMed Web of Science ®Google Scholar
• Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409–1413. doi:10.7314/APJCP.2015.16.4.140925743807
   PubMedGoogle Scholar
• Mohagheghi S, Mousavi JS, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998–2001. Arch Iran Med. 2009;12(1):15–23.19111024
   PubMed Web of Science ®Google Scholar
• Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing epidemiology of common cancers in Southern Iran, 2007–2010: a cross sectional study. PLoS One. 2016;11(5):e0155669. doi:10.1371/journal.pone.015566927219458
   PubMed Web of Science ®Google Scholar
• Vakili M, Pirdehghan A, Adimi M, Sadeghian M, Akhondi M. Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005–2009. J Res Health Sci. 2014;14(3):210–213.25209908
   PubMedGoogle Scholar
• Yavari P, Sadrolhefazi B, Mohagheghi M, et al. An epidemiological analysis of cancer data in an Iranian hospital during the last three decades. Asian Pac J Cancer Prev. 2008;9(1):145–150.18439094
   PubMedGoogle Scholar
• Rahimi Z, Kasraei R, Najafi F, et al. Cancer notification at a referral hospital of Kermanshah, Western Iran (2006–2009). Asian Pac J Cancer Prev. 2015;16(1):133–137. doi:10.7314/APJCP.2015.16.1.13325640340
   PubMedGoogle Scholar
• Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S. Incidence trend and epidemiology of common cancers in the center of Iran. Glob J Health Sci. 2016;8(3):146. doi:10.5539/gjhs.v8n3p146
   Google Scholar
• Rafiemanesh H, Lotfi Z, Bakhtazad S, Ghoncheh M, Salehiniya H. The epidemiological and histological trend of bladder cancer in Iran. J Cancer Res Ther. 2018;14(3):532. doi:10.4103/0973-1482.17213429893311
   PubMed Web of Science ®Google Scholar
• Enayatrad M, Mirzaei M, Salehiniya H, Reza M. Trends in incidence of common cancers in Iran. Asian Pac J Cancer Prev. 2016;17(S3):39–42. doi:10.7314/APJCP.2016.17.S3.3927165205
   PubMedGoogle Scholar
• Koohi F, Salehiniya H. The trend of incidence of bladder cancer in Iran, 2003–2009. Urmia Med J. 2015;26(1):1–9.
   Google Scholar
• Alireza S, Mehdi N, Ali M, Alireza M, Reza M, Parkin D. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev. 2005;6(3):359.16236000
   PubMedGoogle Scholar
• Mahdavi S, Amoori N, Salehiniya H, Almasi Z, Enayatrad M. Trend of bladder cancer mortality in Iran (2006 to 2010). Int J Epidemiol Res. 2015;2(4):184–189.
   Google Scholar
• Nikfarjam Z, Massoudi T, Salehi M, Salehi M, Khoshroo F. Demographic survey of four thousand patients with 10 common cancers in North Eastern Iran over the past three decades. Asian Pac J Cancer Prev. 2014;15(23):10193–10198. doi:10.7314/APJCP.2014.15.23.1019325556447
   PubMedGoogle Scholar
• Farahmand M, Khadem AF, Medhati M, Shokrpour N, Joulaei H, Mehrbani D. Trend of bladder cancer in Fars province, southern Iran, 2002–2006. Iran Red Crescent Med J. 2009;11(4):470–472.
   Web of Science ®Google Scholar
• Roshani Z, Akbari AK, Shati M, Sahaf R. Prevalence of types of cancers in the elderly covered by insurance of the Islamic Republic of Iran Broadcasting Company in 2015-comparison with younger groups. Asian Pac J Cancer Prev. 2016;17(S3):269–273. doi:10.7314/APJCP.2016.17.S3.26927165237
   PubMedGoogle Scholar